Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial by Cree, Bruce AC, Selmaj, Krzysztof W, Steinman, Lawrence, Comi, Giancarlo, Bar-Or, Amit, Arnold, Douglas L, Hartung, Hans-Peter, Montalbán, Xavier, Havrdová, Eva K, Sheffield, James K, Minton, Neil, Cheng, Chun-Yen, Silva, Diego, Kappos, Ludwig, Cohen, Jeffrey A

Get full text

Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study by Cohen, Jeffrey A, Comi, Giancarlo, Arnold, Douglas L, Bar-Or, Amit, Selmaj, Krzysztof W, Steinman, Lawrence, Havrdová, Eva K, Cree, Bruce AC, Montalbán, Xavier, Hartung, Hans-Peter, Huang, Vivian, Frohna, Paul, Skolnick, Brett E, Kappos, Ludwig

Get full text

The risk of secondary progressive multiple sclerosis is geographically determined but modifiable by Sharmin, Sifat, Roos, Izanne, Simpson-Yap, Steve, Malpas, Charles, Sánchez, Marina M, Ozakbas, Serkan, Horakova, Dana, Havrdova, Eva K, Patti, Francesco, Alroughani, Raed, Izquierdo, Guillermo, Eichau, Sara, Boz, Cavit, Zakaria, Magd, Onofrj, Marco, Lugaresi, Alessandra, Weinstock-Guttman, Bianca, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Terzi, Murat, Amato, Maria Pia, Karabudak, Rana, Grand’Maison, Francois, Khoury, Samia J, Grammond, Pierre, Lechner-Scott, Jeannette, Buzzard, Katherine, Skibina, Olga, van der Walt, Anneke, Butzkueven, Helmut, Turkoglu, Recai, Altintas, Ayse, Maimone, Davide, Kermode, Allan, Shalaby, Nevin, Pesch, Vincent V, Butler, Ernest, Sidhom, Youssef, Gouider, Riadh, Mrabet, Saloua, Gerlach, Oliver, Soysal, Aysun, Barnett, Michael, Kuhle, Jens, Hughes, Stella, Sa, Maria J, Hodgkinson, Suzanne, Oreja-Guevara, Celia, Ampapa, Radek, Petersen, Thor, Ramo-Tello, Cristina, Spitaleri, Daniele, McCombe, Pamela, Taylor, Bruce, Prevost, Julie, Foschi, Matteo, Slee, Mark, McGuigan, Chris, Laureys, Guy, Hijfte, Liesbeth V, de Gans, Koen, Solaro, Claudio, Oh, Jiwon, Macdonell, Richard, Aguera-Morales, Eduardo, Singhal, Bhim, Gray, Orla, Garber, Justin, Wijmeersch, Bart V, Simu, Mihaela, Castillo-Triviño, Tamara, Sanchez-Menoyo, Jose L, Khurana, Dheeraj, Al-Asmi, Abdullah, Al-Harbi, Talal, Deri, Norma, Fragoso, Yara, Lalive, Patrice H, Sinnige, L G F, Shaw, Cameron, Shuey, Neil, Csepany, Tunde, Sempere, Angel P, Moore, Fraser, Decoo, Danny, Willekens, Barbara, Gobbi, Claudio, Massey, Jennifer, Hardy, Todd, Parratt, John, Kalincik, Tomas

Get full text

Treatment satisfaction, safety, and tolerability of cladribine tablets in patients with highly active relapsing multiple sclerosis: CLARIFY-MS study 6-month interim analysis by Brochet, Bruno, Hupperts, Raymond, Langdon, Dawn, Solari, Alessandra, Piehl, Fredrik, Lechner-Scott, Jeannette, Montalban, Xavier, Selmaj, Krzysztof, Valis, Martin, Rejdak, Konrad, Havrdova, Eva K., Patti, Francesco, Alexandri, Nektaria, Nolting, Axel, Keller, Birgit

Get full text

The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies by Andersen, Johanna B, Sharmin, Sifat, Lefort, Mathilde, Koch-Henriksen, Nils, Sellebjerg, Finn, Sørensen, Per Soelberg, Hilt Christensen, Claudia C, Rasmussen, Peter V, Jensen, Michael B, Frederiksen, Jette L, Bramow, Stephan, Mathiesen, Henrik K, Schreiber, Karen I, Horakova, Dana, Havrdova, Eva K, Alroughani, Raed, Izquierdo, Guillermo, Eichau, Sara, Ozakbas, Serkan, Patti, Francesco, Onofrj, Marco, Lugaresi, Alessandra, Terzi, Murat, Grammond, Pierre, Grand Maison, Francois, Yamout, Bassem, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Boz, Cavit, Trojano, Maria, McCombe, Pamela, Slee, Mark, Lechner-Scott, Jeannette, Turkoglu, Recai, Sola, Patrizia, Ferraro, Diana, Granella, Franco, Shaygannejad, Vahid, Prevost, Julie, Skibina, Olga, Solaro, Claudio, Karabudak, Rana, Wijmeersch, Bart V, Csepany, Tunde, Spitaleri, Daniele, Vucic, Steve, Casey, Romain, Debouverie, Marc, Edan, Gilles, Ciron, Jonathan, Ruet, Aurélie, Sèze, Jérôme D, Maillart, Elisabeth, Zephir, Hélène, Labauge, Pierre, Defer, Gilles, Lebrun, Christine, Moreau, Thibault, Berger, Eric, Clavelou, Pierre, Pelletier, Jean, Stankoff, Bruno, Gout, Olivier, Thouvenot, Eric, Heinzlef, Olivier, Al-Khedr, Abdullatif, Bourre, Bertrand, Casez, Olivier, Cabre, Philippe, Montcuquet, Alexis, Wahab, Abir, Camdessanché, Jean-Philippe, Marousset, Aude, Patry, Ivania, Hankiewicz, Karolina, Pottier, Corinne, Maubeuge, Nicolas, Labeyrie, Céline, Nifle, Chantal, Leray, Emmanuelle, Laplaud, David A, Butzkueven, Helmut, Kalincik, Tomas, Vukusic, Sandra, Magyari, Melinda

Get full text

Endocrine and multiple sclerosis outcomes in patients with autoimmune thyroid events in the alemtuzumab CARE-MS studies by Dayan, Colin M., Lecumberri, Beatriz, Muller, Ilaria, Ganesananthan, Sashiananthan, Hunter, Samuel F., Selmaj, Krzysztof W., Hartung, Hans-Peter, Havrdova, Eva K., LaGanke, Christopher C., Ziemssen, Tjalf, Van Wijmeersch, Bart, Meuth, Sven G., Margolin, David H., Poole, Elizabeth M., Baker, Darren P., Senior, Peter A.

Get full text

2221 Evaluating no evidence of disease activity (NEDA) with Ozanimod in patients with relapsing multiple sclerosis (RMS): post hoc analysis of phase 3 RADIANCE and DAYBREAK by Kappos, Ludwig, Comi, Giancarlo, Selmaj, Krzysztof W, Steinman, Lawrence, Bar-Or, Amit, Arnold, Douglas L, Hartung, Hans-Peter, Montalbán, Xavier, Havrdová, Eva K, Pachai, Chahin, Sheffield, James K, Cheng, Chun-Yen, Silva, Diego, Vaile, John, Morello, Jean Pierre, Cohen, Jeffrey A, Guevara-Harrison, Narelle, Cree, Bruce AC

Request full text

004 Pregnancy-related relapse in natalizumab, fingolimod and dimethyl fumarate-treated women with multiple sclerosis by Yeh, Wei Z, Widyastuti, Putu A, Walt, Anneke Van der, Stankovich, Jim, Havrdova, Eva K, Horakova, Dana, Vodehnalova, Karolina, Ozakbas, Serkan, Eichau, Sara, Duquette, Pierre, Kalincik, Tomas, Patti, Francesco, Boz, Cavit, Terzi, Murat, Yamout, Bassem, Lechner-Scott, Jeannette, Sola, Patrizia, Skibina, Olga, Barnett, Michael, Onofrj, Marco, Sá, Maria J, McCombe, Pamela, Grammond, Pierre, Ampapa, Radek, Grand’Maison, Francois, Bergamaschi, Roberto, Spitaleri, Daniele LA, Pesch, Vincent Van, Cartechini, Elisabetta, Hodgkinson, Suzanne, Soysal, Aysun, Saiz, Albert, Gresle, Melissa, Uher, Tomas, Maimone, Davide, Turkoglu, Recai, Hupperts, Raymond MM, Amato, Maria Pia, Granella, Franco, Oreja-Guevara, Celia, Altintas, Ayse, Macdonell, Richard, Castillo-Trivino, Tamara, Butzkueven, Helmut, Alroughani, Raed, Jokubaitis, Vilija G, Registry, MSBase

Request full text

Delay from treatment start to full effect of immunotherapies for multiple sclerosis by Roos, Izanne, Leray, Emmanuelle, Frascoli, Federico, Casey, Romain, Brown, J William L, Horakova, Dana, Havrdova, Eva K, Trojano, Maria, Patti, Francesco, Izquierdo, Guillermo, Eichau, Sara, Onofrj, Marco, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc, Grammond, Pierre, Sola, Patrizia, Ferraro, Diana, Ozakbas, Serkan, Bergamaschi, Roberto, Sá, Maria José, Cartechini, Elisabetta, Boz, Cavit, Granella, Franco, Hupperts, Raymond, Terzi, Murat, Lechner-Scott, Jeannette, Spitaleri, Daniele, Van Pesch, Vincent, Soysal, Aysun, Olascoaga, Javier, Prevost, Julie, Aguera-Morales, Eduardo, Slee, Mark, Csepany, Tunde, Turkoglu, Recai, Sidhom, Youssef, Gouider, Riadh, Van Wijmeersch, Bart, McCombe, Pamela, Macdonell, Richard, Coles, Alasdair, Malpas, Charles B, Butzkueven, Helmut, Vukusic, Sandra, Kalincik, Tomas

Get full text

Improvements in Quality of Life at 1 Year in Patients Treated with Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis: An Interim Analysis of Clarify-MS by Solari, Alessandra, Montalban, Xavier, Lechner-Scott, Jeannette, Piehl, Fredrik, Brochet, Bruno, Langdon, Dawn, Hupperts, Raymond, Selmaj, Krzysztof, Havrdova, Eva K., Patti, Francesco, Brieva, Luis, Maida, Eva Maria, Alexandri, Nektaria, Kamudoni, Paul, Nolting, Axel, Keller, Birgit

Get full text

Improvements in Quality of Life Over 2 Years in Patients Treated with Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis: Final Analysis of CLARIFY-MS by Solari, Alessandra, Montalban, Xavier, Lechner-Scott, Jeannette, Piehl, Fredrik, Brochet, Bruno, Langdon, Dawn, Hupperts, Raymond, Selmaj, Krzysztof, Havrdova, Eva K., Patti, Francesco, Brieva, Luis, Maida, Eva Maria, Alexandri, Nektaria, Smyk, Andrzej, Nolting, Axel, Keller, Birgit, on behalf of the CLARIFY-MS Investigators

Get full text

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial by Comi, Giancarlo, Kappos, Ludwig, Selmaj, Krzysztof W, Bar-Or, Amit, Arnold, Douglas L, Steinman, Lawrence, Hartung, Hans-Peter, Montalban, Xavier, Kubala Havrdová, Eva, Cree, Bruce A C, Sheffield, James K, Minton, Neil, Raghupathi, Kartik, Ding, Ning, Cohen, Jeffrey A

Get full text

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial by Cohen, Jeffrey A, Comi, Giancarlo, Selmaj, Krzysztof W, Bar-Or, Amit, Arnold, Douglas L, Steinman, Lawrence, Hartung, Hans-Peter, Montalban, Xavier, Kubala Havrdová, Eva, Cree, Bruce A C, Sheffield, James K, Minton, Neil, Raghupathi, Kartik, Huang, Vivian, Kappos, Ludwig

Get full text

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study by Kappos, Ludwig, Prof, Gold, Ralf, Prof, Miller, David H, Prof, MacManus, David G, MSc, Havrdova, Eva, MD, Limmroth, Volker, MD, Polman, Chris H, Prof, Schmierer, Klaus, PhD, Yousry, Tarek A, MD, Yang, Minhua, MS, Eraksoy, Mefkûre, Prof, Meluzinova, Eva, MD, Rektor, Ivan, MD, Dawson, Katherine T, MD, Sandrock, Alfred W, MD, O'Neill, Gilmore N, MB

Get full text

Real-Life Outcome in Multiple Sclerosis in the Czech Republic by Havrdova, Eva, Pavelcova, Miluse, Jönsson, Linus, Kobelt, Gisela

Get full text

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis by Montalban, Xavier, Gold, Ralf, Thompson, Alan J, Otero-Romero, Susana, Amato, Maria Pia, Chandraratna, Dhia, Clanet, Michel, Comi, Giancarlo, Derfuss, Tobias, Fazekas, Franz, Hartung, Hans Peter, Havrdova, Eva, Hemmer, Bernhard, Kappos, Ludwig, Liblau, Roland, Lubetzki, Catherine, Marcus, Elena, Miller, David H, Olsson, Tomas, Pilling, Steve, Selmaj, Krysztof, Siva, Aksel, Sorensen, Per Soelberg, Sormani, Maria Pia, Thalheim, Christoph, Wiendl, Heinz, Zipp, Frauke

Get full text

Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study by Devonshire, Virginia, MD, Havrdova, Eva, MD, Radue, Ernst Wilhelm, Prof, O'Connor, Paul, MD, Zhang-Auberson, Lixin, MD, Agoropoulou, Catherine, PhD, Häring, Dieter Adrian, PhD, Francis, Gordon, MD, Kappos, Ludwig, Prof

Get full text

Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring by Kappos, Ludwig, Prof, Bates, David, Prof, Edan, Gilles, Prof, Eraksoy, Mefkûre, MD, Garcia-Merino, Antonio, MD, Grigoriadis, Nikolaos, MD, Hartung, Hans-Peter, Prof, Havrdová, Eva, MD, Hillert, Jan, MD, Hohlfeld, Reinhard, Prof, Kremenchutzky, Marcelo, MD, Lyon-Caen, Olivier, Prof, Miller, Ariel, MD, Pozzilli, Carlo, Prof, Ravnborg, Mads, MD, Saida, Takahiko, MD, Sindic, Christian, Prof, Vass, Karl, MD, Clifford, David B, Prof, Hauser, Stephen, Prof, Major, Eugene O, PhD, O'Connor, Paul W, Prof, Weiner, Howard L, Prof, Clanet, Michel, Prof, Gold, Ralf, Prof, Hirsch, Hans H, Prof, Radü, Ernst-Wilhelm, Prof, Sørensen, Per Soelberg, Prof, King, John, MD

Get full text

Using Serum Metabolomics to Predict Development of Anti-drug Antibodies in Multiple Sclerosis Patients Treated With IFNβ by Waddington, Kirsty E, Papadaki, Artemis, Coelewij, Leda, Adriani, Marsilio, Nytrova, Petra, Kubala Havrdova, Eva, Fogdell-Hahn, Anna, Farrell, Rachel, Dönnes, Pierre, Pineda-Torra, Inés, Jury, Elizabeth C

Get full text

Improvements in quality of life over 2 years with cladribine tablets in people with relapsing multiple sclerosis: The CLARIFY-MS study by Brochet, Bruno, Solari, Alessandra, Lechner-Scott, Jeannette, Piehl, Fredrik, Langdon, Dawn, Hupperts, Raymond, Selmaj, Krzysztof, Patti, Francesco, Brieva, Luis, Maida, Eva Maria, Alexandri, Nektaria, Smyk, Andrzej, Nolting, Axel, Keller, Birgit, Montalban, Xavier, Kubala Havrdova, Eva

Get full text